Sign Up Today and Learn More About Metagen Therapeutics Stock
Invest in or calculate the value of your shares in Metagen Therapeutics or other pre-IPO companies through EquityZen's platform.
Metagen Therapeutics Stock
Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.
About Metagen Therapeutics Stock
Founded
2020
Industries
Artificial Intelligence, Software, Data and Analytics
Metagen Therapeutics Press Mentions
Stay in the know about the latest news on Metagen Therapeutics
「腸いいね！プロジェクト」始動 山形県鶴岡市を”腸”いいまちへ ”食文化”と”腸内細菌”で腸活のまちづくり
prtimes • May 18, 2026
【世界IBDデー】WORLD IBD DAY 2026 ライトアップイベント IN JAPAN 東京にて、「献便」普及を目的としたブースを出展
prtimes • May 12, 2026
Metagen Therapeutics Raises ¥3.52 Billion in Series B Funding for Fecal Microbiota Transplantation, Bringing Total to ¥5.46 Billion
thebridge • Feb 27, 2026
メタジェンセラピューティクス、シリーズB総額で約35億円調達、 累計調達額54億円以上に
prtimes • Feb 26, 2026
Metagen Therapeutics, a Microbiome Drug Discovery Company, Raises Approximately ¥2.3 Billion in Series B
thebridge • Sep 19, 2025
Metagen Therapeutics Management
Leadership team at Metagen Therapeutics
Co-Founder, Director & Chief Technology Officer
Takuji Yamada
Co-Founder, Director & Chief Medical Officer
Dai Ishikawa
Join now and verify your accreditation status to gain access to:
- Metagen Therapeutics Current Valuation
- Metagen Therapeutics Stock Price
- Metagen Therapeutics Management
- Available deals in Metagen Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Metagen Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Metagen Therapeutics Revenue and Financials
- Metagen Therapeutics Highlights
- Metagen Therapeutics Business Model
- Metagen Therapeutics Risk Factors
- Metagen Therapeutics Research Report from SACRA Research
Trading Metagen Therapeutics Stock
How to invest in Metagen Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Metagen Therapeutics through EquityZen funds. These investments are made available by existing Metagen Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Metagen Therapeutics stock?
Shareholders can sell their Metagen Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."